Hereditary Colorectal Cancer
Top Cited Papers
- 6 March 2003
- journal article
- review article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 348 (10) , 919-932
- https://doi.org/10.1056/nejmra012242
Abstract
The annual incidence of colorectal cancer in the United States is approximately 148,300 (affecting 72,600 males and 75,700 females), with 56,600 deaths (in 27,800 males and 28,800 females).1 The lifetime risk of colorectal cancer in the general population is about 5 to 6 percent.1 Patients with a familial risk — those who have two or more first- or second-degree relatives (or both) with colorectal cancer — make up approximately 20 percent of all patients with colorectal cancer, whereas approximately 5 to 10 percent of the total annual burden of colorectal cancer is mendelian in nature — that is, it is inherited in an autosomal dominant manner. In this review we will focus on the two major forms of hereditary colorectal cancer, familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer.Keywords
This publication has 82 references indexed in Scilit:
- Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia ChromosomeNew England Journal of Medicine, 2001
- Genetic Testing for Cancer PredispositionAnnual Review of Medicine, 2001
- The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous PolyposisNew England Journal of Medicine, 2000
- Predictive genetic testing for hereditary non-polyposis colorectal cancer: Uptake and long-term satisfactionInternational Journal of Cancer, 2000
- Genetic pathways in colorectal and other cancersEuropean Journal Of Cancer, 1999
- Invited editorialDiseases of the Colon & Rectum, 1999
- Molecular Classification of the Inherited Hamartoma Polyposis Syndromes: Clearing the Muddied WatersAmerican Journal of Human Genetics, 1998
- DNA mismatch repair gene mutations in 55 kindreds with verified or putative hereditary non-polyposis colorectal cancerHuman Molecular Genetics, 1996
- The protocol for a european double-blind trial of aspirin and resistant starch in familial adenomatous polyposis: The capp studyEuropean Journal Of Cancer, 1995
- The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC)Diseases of the Colon & Rectum, 1991